When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ALPMF - Astellas application accepted in China for gilteritinib for type of leukemia
Astellas Pharma Inc
China's National Medical Products Administration has accepted for review Astellas Pharma's (OTCPK:ALPMF) marketing application seeking approval to use Xospata (gilteritinib) to treat adults with FLT3 mutation-positive acute myeloid leukemia (AML), a type of blood cancer with a poor prognosis.
More news on: Astellas Pharma Inc., Astellas Pharma Inc., Healthcare stocks news,